EAACI Position Paper

		45 Articles
To print, select all of the articles you wish to print and click ctrl/cmd + p		Tweet

EAACI Position Paper

Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases

Baumann, R. et al.

EAACI Position Paper

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

Pfaar, O. et al.

EAACI Position Paper

Management of patients with chronic rhinosinusitis during the COVID-19 pandemic—An EAACI position paper

Klimek, L. et al.

EAACI Position Paper

ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Bousquet J. et al.

EAACI Position Paper

Biologicals in atopic disease in pregnancy: An EAACI position paper

Pfaller B. et al.

EAACI Position Paper

Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

Roth-Walter F. et al.

EAACI Position Paper

Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I

Sokolowska M. et al.

EAACI Position Paper

The development of birch pollen seasons over 30 years in Munich, Germany—An EAACI Task Force report

Karl-Christian Bergmann et al.

EAACI Position Paper

Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group

Moscato G. et al.

EAACI Position Paper

Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement

Vultaggio A. et al.

EAACI Position Paper

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper

Gelincik A. et al.

EAACI Position Paper

Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Sokolowska M. et al.

EAACI Position Paper

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet J. et al.

EAACI Position Paper

Biologicals in atopic disease in pregnancy: an EAACI position paper

Pfaller B. et al.

EAACI Position Paper

GENDER AND OCCUPATIONAL ALLERGY (GOA): Report from the task force of the EAACI Environmental & Occupational Allergy Interest Group

Moscato G. et al.

EAACI Position Paper

Current perspective on eicosanoids in asthma and allergic diseases - EAACI Task Force consensus report, part I

Sokolowska M. et al.

EAACI Position Paper

Placebo effects in allergen immunotherapy – an EAACI Task Force Position Paper

Pfaar O. et al.

EAACI Position Paper

Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement

Vultaggio A. et al.

EAACI Position Paper

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic – an EAACI/ARIA Position Paper

Pfaar O. et al.

EAACI Position Paper

Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives – a report of the European Academy of Allergy and Clinical Immunology (EAACI)

Sokolowska M. et al.

EAACI Position Paper

Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases – An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

Roth-Walter F. et al.

EAACI Position Paper

Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review-An EAACI position paper

Oussalah A. et al.

EAACI Position Paper

Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper

Romano A. et al.

EAACI Position Paper

Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Klimek L. et al.

EAACI Position Paper

Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants-An EAACI Position Paper

Meyer R. et al.

EAACI Position Paper

The effectiveness of interventions to improve self-management for adolescents and young adults with allergic conditions: A systematic review

Knibb R.C. et al.

EAACI Position Paper

Understanding the challenges faced by adolescents and young adults with allergic conditions: A systematic review

Vazquez-Ortiz M. et al.

EAACI Position Paper

EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma

Venter, C. et al.

EAACI Position Paper

State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)

Jensen-Jarolim E. et al.

EAACI Position Paper

The role of mobile health technologies in allergy care: An EAACI position paper

Matricardi P. M. et al.

EAACI Position Paper

EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis

Venter, C. et al.

EAACI Position Paper

The role of mobile health technologies in allergy care: An EAACI position paper

Matricardi, P. M. et al.

EAACI Position Paper

An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions

Garvey, L. H. et al.

EAACI Position Paper

Management of ocular allergy.

Leonardi, A. et al.

EAACI Position Paper

Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)a EAACI position paper

Kowalski, M. L. et al.

EAACI Position Paper

EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

Brockow, K. et al.

EAACI Position Paper

Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document

Agache, I. et al.

EAACI Position Paper

A EAACI drug allergy interest group survey on how European allergy specialists deal with beta-lactam allergy

Jose Torres, M. et al.

EAACI Position Paper

Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper

Roth-Walter, F. et al.

EAACI Position Paper

EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animals

Pali-Schoell, I. et al.

EAACI Position Paper

Inverted U-shaped relationship between vitamin D and ever-reported eczema in US adults

Wei, J. et al.

EAACI Position Paper

Toward clinically applicable biomarkers for asthma: An EAACI position paper

Diamant, Z. et al.

EAACI Position Paper

Food processing and occupational respiratory allergy- An EAACI position paper

Jeebhay, M. F. et al.

EAACI Position Paper

Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

Agache, I. et al.

EAACI Position Paper

45 Articles

To print, select all of the articles you wish to print and click ctrl/cmd + p

EAACI Position Paper

Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases

Baumann, R. et al.

EAACI Position Paper

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

Pfaar, O. et al.

EAACI Position Paper

Management of patients with chronic rhinosinusitis during the COVID-19 pandemic—An EAACI position paper

Klimek, L. et al.

EAACI Position Paper

ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Bousquet J. et al.

EAACI Position Paper

Biologicals in atopic disease in pregnancy: An EAACI position paper

Pfaller B. et al.

EAACI Position Paper

Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

Roth-Walter F. et al.

EAACI Position Paper

Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I

Sokolowska M. et al.

EAACI Position Paper

The development of birch pollen seasons over 30 years in Munich, Germany—An EAACI Task Force report

Karl-Christian Bergmann et al.

EAACI Position Paper

Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group

Moscato G. et al.

EAACI Position Paper

Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement

Vultaggio A. et al.

EAACI Position Paper

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper

Gelincik A. et al.

EAACI Position Paper

Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Sokolowska M. et al.

EAACI Position Paper

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet J. et al.

EAACI Position Paper

Biologicals in atopic disease in pregnancy: an EAACI position paper

Pfaller B. et al.

EAACI Position Paper

GENDER AND OCCUPATIONAL ALLERGY (GOA): Report from the task force of the EAACI Environmental & Occupational Allergy Interest Group

Moscato G. et al.

EAACI Position Paper

Current perspective on eicosanoids in asthma and allergic diseases - EAACI Task Force consensus report, part I

Sokolowska M. et al.

EAACI Position Paper

Placebo effects in allergen immunotherapy – an EAACI Task Force Position Paper

Pfaar O. et al.

EAACI Position Paper

Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement

Vultaggio A. et al.

EAACI Position Paper

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic – an EAACI/ARIA Position Paper

Pfaar O. et al.

EAACI Position Paper

Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives – a report of the European Academy of Allergy and Clinical Immunology (EAACI)

Sokolowska M. et al.

EAACI Position Paper

Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases – An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

Roth-Walter F. et al.

EAACI Position Paper

Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review-An EAACI position paper

Oussalah A. et al.

EAACI Position Paper

Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper

Romano A. et al.

EAACI Position Paper

Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Klimek L. et al.

EAACI Position Paper

Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants-An EAACI Position Paper

Meyer R. et al.

EAACI Position Paper

The effectiveness of interventions to improve self-management for adolescents and young adults with allergic conditions: A systematic review